Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility

While progress has been made in treating cancer, cytotoxic chemotherapeutic agents are still the most widely used drugs and are associated with severe side-effects. Drugs that target unique molecular signalling pathways are needed for treating cancer with low or no intrinsic toxicity to normal cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Jalisa H., De Los Santos, Zeus, Devi, Saroja N., Kaluz, Stefan, Van Meir, Erwin G., Zingales, Sarah K., Wang, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009948/
https://www.ncbi.nlm.nih.gov/pubmed/28766956
http://dx.doi.org/10.1080/14756366.2017.1347784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009948/
https://www.ncbi.nlm.nih.gov/pubmed/28766956
http://dx.doi.org/10.1080/14756366.2017.1347784

Ejemplares similares